Cross-Sector entity
2nd U.S. Circuit Court of Appeals is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category. The tracked stories average 2 original sources each.
2 verified stories tracked
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
2nd U.S. Circuit Court of Appeals is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category. The tracked stories average 2 original sources each. Judge Denise Cote appears in 2 tracked Cross-Sector stories from July 25, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Judge Denise Cote. Shared-story counts are live from our verified record — not editorial picks.
The legal reinstatement of Tylenol-autism lawsuits pressures healthcare providers to reconcile conflicting evidence on acetaminophen safety in pregnancy, potentially altering clinical guidance, patient counseling, and EHR decision support.
The 2nd Circuit ruling revives mass tort litigation linking prenatal acetaminophen to autism, exposing Kenvue and retailers to billions in potential liability. The decision hinges on admissibility of novel scientific evidence, challenging Daubert standards and regulatory orthodoxy.
Source: fox5atlanta.com · fox32chicago.com
